Harmony Biosciences Holdings, Inc. (HRMY) › Shareholders' EquityHarmony Biosciences Holdings, Inc. (HRMY) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: -$242.67M2019: -$422.86M2020: $97.18M2021: $186.51M2022: $402.84M2023: $466.99M2024: $659.15M2025: $870.22M$870.22M2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$870.22M+32.0%2024$659.15M+41.1%2023$466.99M+15.9%2022$402.84M+116.0%2021$186.51M+91.9%2020$97.18M+123.0%2019-$422.86M-74.3%2018-$242.67M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share